- Home
- PMVP vs CDLX Comparison
PMVP vs CDLX Comparison
Compare PMVP & CDLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PMVP | CDLX |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.8M | 69.7M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | PMVP | CDLX |
|---|---|---|
| Price | $1.56 | $0.67 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $5.00 | $2.25 |
| AVG Volume (30 Days) | ★ 815.0K | 710.4K |
| Earning Date | 01-01-0001 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.13 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $233,273,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $46.84 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.82 | $0.67 |
| 52 Week High | $1.88 | $3.28 |
Technical Indicators
Market Signals| Indicator | PMVP | CDLX |
|---|---|---|
| Relative Strength Index (RSI) | 60.27 | 30.48 |
| Support Level | $1.32 | N/A |
| Resistance Level | $1.56 | $1.04 |
| Average True Range (ATR) | 0.14 | 0.06 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 60.71 | 3.05 |
Price Performance
Historical ComparisonAbout PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About CDLX Cardlytics Inc.
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K. and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.